During the past decade, Eastern Cooperative Oncology Group conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 24 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 14 clinical trials were completed. i.e. 1400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eastern Cooperative Oncology Group" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "ECOG-ACRIN Cancer Research Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Eastern Cooperative Oncology Group" are "Advanced Lymphoma" (20 trials), "Advanced Malignant Solid Neoplasm" (20 trials), "Refractory Lymphoma" (20 trials), "Refractory Malignant Solid Neoplasm" (20 trials) and "Hematopoietic and Lymphoid Cell Neoplasm" (19 trials). Many other conditions were trialed in "Eastern Cooperative Oncology Group" in a lesser frequency.

Most popular intervention types in "Eastern Cooperative Oncology Group" are "Drug" (66 trials), "Other" (32 trials), "Biological" (17 trials), "Procedure" (9 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (24 trials), "bevacizumab" (6 trials), "bortezomib" (6 trials), "cyclophosphamide" (6 trials) and "Laboratory Biomarker Analysis" (5 trials). Other intervention names were less common.

The vast majority of trials in "Eastern Cooperative Oncology Group" are 64 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Eastern Cooperative Oncology Group". undefined are not yet recruiting, 4 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Eastern Cooperative Oncology Group, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Eastern Cooperative Oncology Group, 3 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".